Company news
Easton Pharmaceuticals Inc news in 2018
Easton Pharmaceuticals Inc's news releases, calls and decks from 2018, newest first.
Easton Pharmaceuticals Is Short-Listed to Acquire an Interest in an Operating Casino and Hotel Resort in Loutraki, Greece with Revenues in Excess of 60 Million Euro Per Year
October 1, 2018
Easton Pharmaceuticals Reaches Agreement to Take Over Hotel and $17,000,000 Real Estate Asset in Heart of Toronto, Canada
September 27, 2018
Easton Pharmaceuticals Announces It Has Entered Into High Level Negotiations To Take Over a Profitable Hotel and a $17,000,000 Real Estate Asset Located In The Heart of Toronto, Ontario, Canada
September 11, 2018
Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum
August 29, 2018
Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro Per Year
August 22, 2018
Easton Pharmaceuticals Acquires Interest in Development Project With in Excess of $30 Million in Profit
August 20, 2018
CORRECTION: Easton Acquires Interest in Development Project with in Excess of $30 Million in Profit
August 19, 2018
Easton Acquires Interest in Development Project
August 19, 2018
Easton Pharmaceuticals Inc. Announces the Departure of its Recently Appointed Director
August 12, 2018
Easton’s JV Georgina Property Resumes Operations. Revenues Expected to be in-line with Estimates for the End of the Year
July 26, 2018
Easton Pharmaceuticals Strengthens its Board of Directors While Enhancing Existing Businesses and Moves Towards New Sectors and Industries
June 25, 2018
Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction
June 20, 2018
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
June 11, 2018
Easton Pharmaceuticals Announces That Revenue Generating Operations Have Commenced From Its Alliance Property and Businesses
June 4, 2018
Easton Pharmaceuticals Announces it is Moving Towards a Letter of Intent With an AMPR Applicant Towards a Marijuana Cultivators / Growers License for Canada; Provides Other Updates
April 17, 2018
Easton Pharmaceuticals Announces BAYER Agreement Update
April 16, 2018
Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative
March 21, 2018
Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update
March 14, 2018
Easton Pharmaceuticals Announces Key Management Addition With the Appointment of Dr. Daniel Bagi, M.D. to the Board of Directors; Provides Other Updates
February 20, 2018
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
February 6, 2018
Easton Pharmaceuticals Announces The Signing Of Closed Sub-Distribution Agreement for Product VS-Sense
January 25, 2018
Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company
January 10, 2018